Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 248, pseudogene (RNU6-248P) is a **human genomic pseudogene** corresponding to the U6 small nuclear RNA gene family. U6 snRNA genes encode core components of the spliceosome, but RNU6-248P itself is classified as a **processed pseudogene**—a non-functional genomic locus thought to have arisen from duplication or retrotransposition events, lacking the capacity to encode a functional mature U6 RNA[1][5][9]. While classic pseudogenes are “dead” and nonfunctional, emerging evidence suggests some can be transcribed and exert regulatory effects as non-coding RNAs, for example by acting as competitive endogenous RNAs (ceRNAs) or providing microRNA-binding sites that modulate gene expression[4][8][2]. There is **no direct evidence** that RNU6-248P is expressed or functional, nor is it considered a druggable or therapeutic target. It is primarily annotated as a **genomic feature with no known protein, direct biological activity, or clinical application**[1][9][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 248, pseudogene (RNU6-248P).